Ian F. Smith, EVP, CFO & COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,250 shares at $156.02 ($660K) on 2017-08-07, disclosed to the SEC on 2017-08-09.
Scheduled sale ($660k) by EVP, CFO & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.09 | 400 | $62K | 9.3% |
| 2 | $155.29 | 2,600 | $404K | 61.1% |
| 3 | $156.02 | 1,250 | $195K | 29.5% |
| Total | $155.39 avg | 4,250 | $660K | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |